Warfarin glycosylation invokes a switch from anticoagulant to anticancer activity.
作者信息
Peltier-Pain Pauline, Timmons Shannon C, Grandemange Agnès, Benoit Etienne, Thorson Jon S
机构信息
Laboratory for Biosynthetic Chemistry, University of Wisconsin National, Cooperative Drug Discovery Group Program, Pharmaceutical Sciences, Division, School of Pharmacy, 777 Highland Avenue, Madison, WI 53705, USA.
出版信息
ChemMedChem. 2011 Aug 1;6(8):1347-50. doi: 10.1002/cmdc.201100178. Epub 2011 Jun 28.
Abstract
摘要
相似文献
1
Warfarin glycosylation invokes a switch from anticoagulant to anticancer activity.
ChemMedChem. 2011 Aug 1;6(8):1347-50. doi: 10.1002/cmdc.201100178. Epub 2011 Jun 28.
2
The characterization of potent novel warfarin analogs.
Thromb Res. 1997 Oct 15;88(2):127-36. doi: 10.1016/s0049-3848(97)00224-7.
3
Synthesis and structure-activity relationships of novel warfarin derivatives.
Bioorg Med Chem. 2007 Mar 15;15(6):2414-20. doi: 10.1016/j.bmc.2007.01.014. Epub 2007 Jan 17.
4
[Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].
Rev Med Interne. 2006 Dec;27(12):979-82. doi: 10.1016/j.revmed.2006.09.004. Epub 2006 Oct 11.
5
Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
Toxicology. 2003 Aug 1;189(3):191-8. doi: 10.1016/s0300-483x(03)00133-1.
6
Warfarin and the vitamin K-dependent gamma-carboxylation system.
Trends Mol Med. 2004 Jul;10(7):299-302. doi: 10.1016/j.molmed.2004.05.003.
7
Inhibition of bacterial disulfide bond formation by the anticoagulant warfarin.
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):297-301. doi: 10.1073/pnas.0912952107. Epub 2009 Dec 15.
8
Synthesis and biological activities of octyl 2,3-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2-O-sulfo-alpha-L-fucopyranosyl-(1-->4)-2,3-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2-O-sulfo-alpha-L-fucopyranosyl-(1-->4)-2,3-di-O-sulfo-beta-L-fucopyranoside.
Carbohydr Res. 2004 Aug 23;339(12):2083-90. doi: 10.1016/j.carres.2004.06.006.
9
VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors.
Vitam Horm. 2008;78:227-46. doi: 10.1016/S0083-6729(07)00011-8.
10
Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants.
Clin Pharmacol Ther. 2006 Jul;80(1):7-12. doi: 10.1016/j.clpt.2006.04.008.
引用本文的文献
1
A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy.
Pharmaceutics. 2023 Mar 11;15(3):913. doi: 10.3390/pharmaceutics15030913.
2
A sustainable innovation for the tandem synthesis of sugar-containing coumarin derivatives catalyzed by lipozyme TL IM from in continuous-flow microreactors.
RSC Adv. 2020 Apr 2;10(22):13252-13259. doi: 10.1039/d0ra00879f. eCollection 2020 Mar 30.
3
Synthesis of MeON-Glycoside Derivatives of Oleanolic Acid by Neoglycosylation and Evaluation of Their Cytotoxicity Against Selected Cancer Cell Lines.
Molecules. 2021 Feb 2;26(3):772. doi: 10.3390/molecules26030772.
4
Targeting Iron in Colon Cancer via Glycoconjugation of Thiosemicarbazone Prochelators.
Bioconjug Chem. 2016 Aug 17;27(8):1807-12. doi: 10.1021/acs.bioconjchem.6b00332. Epub 2016 Jul 29.
5
The identification of perillyl alcohol glycosides with improved antiproliferative activity.
J Med Chem. 2014 Sep 11;57(17):7478-84. doi: 10.1021/jm500870u. Epub 2014 Aug 25.
6
Neoglycosylation and neoglycorandomization: Enabling tools for the discovery of novel glycosylated bioactive probes and early stage leads.
Medchemcomm. 2014 Aug 1;5(8):1036-1047. doi: 10.1039/C4MD00117F.
7
Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor.
Chembiochem. 2013 Nov 25;14(17):2263-7. doi: 10.1002/cbic.201300562. Epub 2013 Oct 31.
8
Glucose conjugation for the specific targeting and treatment of cancer.
Chem Sci. 2013 Jun;4(6):2319-2333. doi: 10.1039/C3SC22205E.
9
Synthesis and antibacterial activity of doxycycline neoglycosides.
J Nat Prod. 2013 Sep 27;76(9):1627-36. doi: 10.1021/np4003096. Epub 2013 Aug 29.
10
Direct synthesis of β-N-glycosides by the reductive glycosylation of azides with protected and native carbohydrate donors.
Angew Chem Int Ed Engl. 2013 Jun 3;52(23):6068-71. doi: 10.1002/anie.201301264. Epub 2013 Apr 22.
本文引用的文献
1
Assessment of chemoselective neoglycosylation methods using chlorambucil as a model.
J Med Chem. 2010 Nov 25;53(22):8129-39. doi: 10.1021/jm101024j. Epub 2010 Oct 25.
2
Pharmacogenetics of warfarin.
Annu Rev Med. 2010;61:63-75. doi: 10.1146/annurev.med.070808.170037.
3
Enhancing the divergent activities of betulinic acid via neoglycosylation.
Org Lett. 2009 Jan 15;11(2):461-4. doi: 10.1021/ol8025704.
4
Modifying the glycosidic linkage in digitoxin analogs provides selective cytotoxins.
Bioorg Med Chem Lett. 2008 Jan 15;18(2):670-3. doi: 10.1016/j.bmcl.2007.11.058.
5
The role of oral anticoagulants in tumor biology.
Semin Thromb Hemost. 2007 Oct;33(7):695-8. doi: 10.1055/s-2007-991537.
6
Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases.
J Pharmacol Exp Ther. 2008 Jan;324(1):139-48. doi: 10.1124/jpet.107.129858. Epub 2007 Oct 5.
7
VKORC1: molecular target of coumarins.
J Thromb Haemost. 2007 Jul;5 Suppl 1:1-6. doi: 10.1111/j.1538-7836.2007.02549.x.
8
Model for antibiotic optimization via neoglycosylation: synthesis of liponeoglycopeptides active against VRE.
J Am Chem Soc. 2007 Jul 4;129(26):8150-5. doi: 10.1021/ja068602r. Epub 2007 Jun 12.
9
Highly enantioselective michael addition of cyclic 1,3-dicarbonyl compounds to alpha,beta-unsaturated ketones.
Org Lett. 2007 Feb 1;9(3):413-5. doi: 10.1021/ol062718a.
10
Substrate-directed stereoselectivity in vicinal diamine-catalyzed synthesis of warfarin.
Org Lett. 2006 Nov 9;8(23):5239-42. doi: 10.1021/ol062000v.
Zotero 插件